Please assess the completion status of the following clinical trial:

Trial Title: Efficacy and Safety of the DTS-G2 System in Patients With Axillary Hyperhidrosis

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* baseline gravimetric measurement of spontaneous resting sweat production of at least 50 mg/5 min at room temperature in each axilla~* poor quality-of-life rating on the Hyperhidrosis Disease Severity Scale~* primary focal axillary hyperhidrosis evidenced by at least two of the standard criteria~* female subjects of child-bearing potential must not be pregnant or lactating and must agree to not become pregnant during the course of the study including follow-up period~* female subjects over 40 must have had a mammogram in the last 2 years~* subjects must be willing to comply with study visits and requirements~Exclusion Criteria:~* subject has secondary hyperhidrosis (e.g., endocrinopathy, medications)~* subject has active infection~* subject is pregnant or lactating~* subject has had prior surgery for axillary hyperhidrosis~* subject has had axillary injections of botulinum toxin A in the last year~* subject has used prescription antiperspirants in the last 14 days or plans to use them during the study period~* subject has used oral anticholinergics in the last 4 weeks~* subject is a prisoner or under incarceration~* subject is participating in a another clinical trial (or has in the last 30 days)~* subject has history of cancer (some exceptions)~* subject has a pacemaker or other electronic implant~* subject requires supplemental oxygen

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Treatment with DTS-G2 System (Type: EXPERIMENTAL): Subjects receive treatment with the DTS-G2 System (an energy-based medical device) in both axilla. Multiple treatment sessions may be used.
- Sham treatment (Type: SHAM_COMPARATOR): All elements of the treatment are given except that no energy is delivered. Multiple treatment sessions may be used.

Based on this trial design, predict the completion outcome and termination type (if applicable).